- Home
- BNOX vs CMND Comparison
BNOX vs CMND Comparison
Compare BNOX & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNOX
- CMND
- Stock Information
- Founded
- BNOX 1996
- CMND 2017
- Country
- BNOX Australia
- CMND Canada
- Employees
- BNOX N/A
- CMND N/A
- Industry
- BNOX Biotechnology: Biological Products (No Diagnostic Substances)
- CMND Biotechnology: Pharmaceutical Preparations
- Sector
- BNOX Health Care
- CMND Health Care
- Exchange
- BNOX Nasdaq
- CMND Nasdaq
- Market Cap
- BNOX 6.3M
- CMND 5.3M
- IPO Year
- BNOX 2021
- CMND N/A
- Fundamental
- Price
- BNOX $0.27
- CMND $1.28
- Analyst Decision
- BNOX Strong Buy
- CMND
- Analyst Count
- BNOX 1
- CMND 0
- Target Price
- BNOX $8.00
- CMND N/A
- AVG Volume (30 Days)
- BNOX 691.4K
- CMND 65.9K
- Earning Date
- BNOX 01-01-0001
- CMND 02-05-2025
- Dividend Yield
- BNOX N/A
- CMND N/A
- EPS Growth
- BNOX N/A
- CMND N/A
- EPS
- BNOX N/A
- CMND N/A
- Revenue
- BNOX N/A
- CMND N/A
- Revenue This Year
- BNOX N/A
- CMND N/A
- Revenue Next Year
- BNOX N/A
- CMND N/A
- P/E Ratio
- BNOX N/A
- CMND N/A
- Revenue Growth
- BNOX N/A
- CMND N/A
- 52 Week Low
- BNOX $0.18
- CMND $0.92
- 52 Week High
- BNOX $1.60
- CMND $3.58
- Technical
- Relative Strength Index (RSI)
- BNOX 47.76
- CMND 43.14
- Support Level
- BNOX $0.27
- CMND $1.26
- Resistance Level
- BNOX $0.35
- CMND $1.53
- Average True Range (ATR)
- BNOX 0.03
- CMND 0.09
- MACD
- BNOX 0.00
- CMND -0.00
- Stochastic Oscillator
- BNOX 18.78
- CMND 6.07
About BNOX Bionomics Limited American Depository Shares
Bionomics Ltd is a clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.